Approved for Treatment of cystic fibrosis in patients aged 2 years and older who have at least one F508del mutation in the CFTR gene. Triple combination CFTR modulator: elexacaftor and tezacaftor are CFTR correctors that facilitate cellular processing and trafficking of the F508del-CFTR protein, while ivacaftor is a CFTR… Side effects, costs, interactions, manufacturer, and generic alternatives…
Loading full data from Know Your Drugs Institute…